NeuExcell Therapeutics
Jonathan Sun was elected to their Board in September 2021.
Mr. Sun is the managing partner and chief executive officer of Archimedes Management, Inc, an asset management firm and single-family office. Jonathan co-founded Archimedes after the sale of GENEWIZ, Inc., a private family-owned genetics and genomics services business, to Brooks Automation (BRKS) in 2019. At Archimedes, he has continued his work in healthcare through direct investments in life sciences tools & technologies, clinical diagnostics, and biopharmaceutical drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
NeuExcell Therapeutics
1 followers
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.